pomalidomide has been researched along with pevonedistat in 1 studies
Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (pevonedistat) | Trials (pevonedistat) | Recent Studies (post-2010) (pevonedistat) |
---|---|---|---|---|---|
623 | 121 | 552 | 299 | 11 | 289 |
Protein | Taxonomy | pomalidomide (IC50) | pevonedistat (IC50) |
---|---|---|---|
Ubiquitin-like modifier-activating enzyme 6 | Homo sapiens (human) | 1.8 | |
Ubiquitin-like modifier-activating enzyme 1 | Mus musculus (house mouse) | 1.5 | |
NEDD8-activating enzyme E1 regulatory subunit | Homo sapiens (human) | 0.0471 | |
NEDD8 | Homo sapiens (human) | 0.0047 | |
NEDD8-activating enzyme E1 catalytic subunit | Homo sapiens (human) | 0.0033 | |
SUMO-activating enzyme subunit 1 | Homo sapiens (human) | 8.2 | |
SUMO-activating enzyme subunit 2 | Homo sapiens (human) | 8.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Li, J; Liu, X; Shi, J; Zhang, Z; Zhao, L; Zhou, Y | 1 |
1 review(s) available for pomalidomide and pevonedistat
Article | Year |
---|---|
A review on the treatment of multiple myeloma with small molecular agents in the past five years.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Deubiquitinating Enzymes; Drug Development; Drug Resistance; Histone Deacetylases; Humans; Ikaros Transcription Factor; Immunomodulating Agents; Models, Molecular; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Proteasome Inhibitors; Treatment Outcome; Ubiquitin-Protein Ligases | 2022 |